A mitochondria-targeted antioxidant peptide studied for its ability to reduce oxidative stress, improve mitochondrial function, and protect against ischemia-reperfusion injury.
Diabetes, obesity & metabolism|2022|Mason S et al.|20 citations
AIM: To investigate the effects of mitochondrial-targeted antioxidants (mitoAOXs) on glycaemic control, cardiovascular health, and oxidative stress outcomes in humans. MATERIALS AND METHODS: Randomized controlled trials investigating mitoAOX interven…
ReviewMeta-Analysis
PMID: 35165982
Current heart failure reports|2022|Schwemmlein J, Maack C, Bertero E|43 citations
PURPOSE OF REVIEW: We review therapeutic approaches aimed at restoring function of the failing heart by targeting mitochondrial reactive oxygen species (ROS), ion handling, and substrate utilization for adenosine triphosphate (ATP) production. RECENT…
Review
PMID: 35147851
Journal of applied toxicology : JAT|2022|Lu F et al.|4 citations
There is in vivo and in vitro evidence that exposure to benzene or its metabolites could affect the mitochondrial function. However, the underlying molecular mechanism of mitochondrial damage remains to be elucidated. In this study, exposure of human…
Animal StudyIn Vitro
PMID: 35383983
GeroScience|2022|Whitson J et al.|9 citations
We analyzed the effects of aging on protein abundance and acetylation, as well as the ability of the mitochondrial-targeted drugs elamipretide (SS-31) and nicotinamide mononucleotide (NMN) to reverse aging-associated changes in mouse hearts. Both dru…
Animal Study
PMID: 35416576
Inflammation research : official journal of the European Histamine Research Society ... [et al.]|2022|Peng X et al.|35 citations
BACKGROUND: A20 is an anti-inflammatory molecule in nucleus pulposus (NP) cells. The anti-inflammatory properties of A20 are mainly attributed to its ability to suppress the NF-κB pathway. However, A20 can protect cells from death independently of NF…
In Vitro
PMID: 35426501
Therapeutic advances in rare disease|2022|Kim A et al.|2 citations
INTRODUCTION: Barth syndrome (BTHS) is a rare X-linked disorder characterized by cardiomyopathy, neutropenia, growth abnormalities, and skeletal myopathy. There have been few studies investigating health-related quality of life (HRQoL) in this popula…
PMID: 37180415
Nephron|2022|Pabla N, Bajwa A|42 citations
Acute kidney injury (AKI) is a common clinical disorder associated with decline in renal function because of ischemic and nephrotoxic insults. The pathophysiology of AKI involves multiple cellular mechanisms, such as kidney parenchymal cell (epitheli…
Review
PMID: 34883481
Kidney international|2022|Wang W, Tran P|2 citations
Pharmacotherapies that are safe during pregnancy are lacking for patients with autosomal dominant polycystic kidney disease. In this issue, Daneshgar et al. reveal that administration of the mitochondrial-protective peptide, elamipretide, during preg…
Animal Study
PMID: 35461611
Renal failure|2022|Liu X et al.|28 citations
Chronic kidney disease (CKD) is a severe clinical syndrome with significant socioeconomic impact worldwide. Orderly energy metabolism is essential for normal kidney function and energy metabolism disorders are increasingly recognized as an important…
PMID: 35535500
Physiological reports|2022|Graham Z et al.|9 citations
Spinal cord injury (SCI) leads to major reductions in function, independent living, and quality of life. Disuse and paralysis from SCI leads to rapid muscle atrophy, with chronic muscle loss likely playing a role in the development of the secondary m…
Animal Study
PMID: 35611788
Oxidative medicine and cellular longevity|2022|Zhu Y et al.|45 citations
Mitochondria are essential for eukaryotic cell activity and function, and their dysfunction is associated with the development and progression of renal diseases. In recent years, there has been a rapid development in mitochondria-targeting pharmacolo…
Review
PMID: 35707274
Oxidative medicine and cellular longevity|2022|Deng Y et al.|23 citations
Mycophenolic acid (MPA) may cause gastrointestinal adverse effects by damaging the intestinal epithelial barrier, the underlying mechanisms remain elusive. Studies have demonstrated that oxidative stress caused by reactive oxygen species (ROS) is lin…
Animal Study
PMID: 35847589
Advanced healthcare materials|2022|Zheng Z et al.|87 citations
Mitochondrial dysfunction of cardiomyocytes (CMs) has been identified as a significant pathogenesis of early myocardial infarction (MI). However, only a few agents or strategies have been developed to improve mitochondrial dysfunction for the effecti…
Animal Study
PMID: 35848825
The American journal of sports medicine|2022|Zhang X et al.|9 citations
BACKGROUND: Studies in our laboratory have demonstrated mitochondrial dysfunction in human and animal models of supraspinatus tendinopathy. SS-31 (elamipretide) has been reported to improve mitochondrial function and to be effective in clinical trial…
In Vitro
PMID: 35862638
eLife|2022|Mitchell W et al.|22 citations
Mitochondria play a central role in metabolic homeostasis, and dysfunction of this organelle underpins the etiology of many heritable and aging-related diseases. Tetrapeptides with alternating cationic and aromatic residues such as SS-31 (elamipretid…
In Vitro
PMID: 35913044
Frontiers in medicine|2022|Zhang P et al.|41 citations
Multiple sevoflurane exposure may result in cognitive deficits in neonatal animals. This study attempted to investigate the potential mechanism of sevoflurane-induced neurotoxicity in developing hippocampus. Neonatal animals received sevoflurane anes…
Animal Study
PMID: 35935755
The Journal of bone and joint surgery. American volume|2022|Zhang X et al.|18 citations
BACKGROUND: Prior studies have demonstrated mitochondrial dysfunction in tendinopathy. The objective of this investigation was to explore the potential of SS-31 (elamipretide), a mitochondrial protectant, to improve mitochondrial function and promote…
Animal Study
PMID: 35984013
Heart failure reviews|2022|Obi C et al.|18 citations
Although currently employed therapies for heart failure decrease overall mortality and improve patient quality of life temporarily, the disease is known to progress even for patients who receive all guideline-recommended therapies. This indicates tha…
ReviewAnimal Study
PMID: 35037146
Drug delivery|2022|Yan J et al.|11 citations
Acute myocardial infarction (AMI) is one of the most common ischemic heart diseases. However, lack of sufficient drug concentration (in the ischemic heart) is the major factor of treatment failure. It is urgent for researchers to engineer novel drug…
Animal Study
PMID: 36047255
Orphanet journal of rare diseases|2022|Hornby B et al.|18 citations
BACKGROUND: Natural history studies are increasingly recognized as having an important role in drug development for rare diseases. A phase 3, observational, retrospective, and non-interventional study was designed to establish a natural history contr…
Clinical TrialObservational
PMID: 36056411